GenomicseLifePeer-reviewed
Deep mutational scanning reveals pharmacologically relevant insights into TYK2 signaling and disease
Conor J Howard, Nathan S. Abell, Robert Warneford-Thomson…·Diane E. Dickel
This study uses deep mutational scanning to analyze TYK2 variants and their impact on function and drug response, identifying novel therapeutic targets and degradation strategies.
3 citations